NCT05042661

Brief Summary

To discuss the effects of improving the irritable bowel syndrome patients' quality of life and defecation after implementing acupuncture-like Transcutaneous Electrical nerve stimulation.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2021

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

September 4, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 13, 2021

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 13, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 13, 2023

Completed
Last Updated

January 6, 2026

Status Verified

February 1, 2023

Enrollment Period

2 years

First QC Date

September 4, 2021

Last Update Submit

January 2, 2026

Conditions

Keywords

irritable bowel syndromeacupuncture-like transcutaneous electrical nervestimulationquality of life

Outcome Measures

Primary Outcomes (16)

  • WHOQOL-BREF,Taiwan version

    There are a total of 28 questions on this scale, of which 26 are common questions around the world, and the other 2 are local questions. This questionnaire is a positive question and a five-point scoring system. The higher the score, the better the quality of life.

    pretest

  • WHOQOL-BREF,Taiwan version

    There are a total of 28 questions on this scale, of which 26 are common questions around the world, and the other 2 are local questions. This questionnaire is a positive question and a five-point scoring system. The higher the score, the better the quality of life

    2 weeks after the pretest

  • WHOQOL-BREF,Taiwan version

    There are a total of 28 questions on this scale, of which 26 are common questions around the world, and the other 2 are local questions. This questionnaire is a positive question and a five-point scoring system. The higher the score, the better the quality of life

    4 weeks after the pretest

  • WHOQOL-BREF,Taiwan version

    There are a total of 28 questions on this scale, of which 26 are common questions around the world, and the other 2 are local questions. This questionnaire is a positive question and a five-point scoring system. The higher the score, the better the quality of life

    8 weeks after the pretest

  • irritable bowel syndrome Severity Score

    There are a total of 5 questions on this scale. This questionnaire is a positive question type. The score of each item can be from 0 to 100. Therefore, the overall severity of IBS ranges from 0 to 500. The severity of symptoms can be divided into mild; moderate; severe, the higher the score, the more severe the IBS symptoms

    pretest

  • irritable bowel syndrome Severity Score

    There are a total of 5 questions on this scale. This questionnaire is a positive question type. The score of each item can be from 0 to 100. Therefore, the overall severity of IBS ranges from 0 to 500. The severity of symptoms can be divided into mild; moderate; severe, the higher the score, the more severe the IBS symptoms

    2 weeks after the pretest

  • irritable bowel syndrome Severity Score

    There are a total of 5 questions on this scale. This questionnaire is a positive question type. The score of each item can be from 0 to 100. Therefore, the overall severity of IBS ranges from 0 to 500. The severity of symptoms can be divided into mild; moderate; severe, the higher the score, the more severe the IBS symptoms

    4 weeks after the pretest

  • irritable bowel syndrome Severity Score

    There are a total of 5 questions on this scale. This questionnaire is a positive question type. The score of each item can be from 0 to 100. Therefore, the overall severity of IBS ranges from 0 to 500. The severity of symptoms can be divided into mild; moderate; severe, the higher the score, the more severe the IBS symptoms

    8 weeks after the pretest

  • Irritable Bowel Syndrome Quality of Life

    This questionnaire has a total of 34 questions, all of which are positive questions, and are scored with five points, divided into 1 point = completely no, 2 points = a little bit, 3 points = medium, 4 points = equivalent, 5 points = extreme. The score range is 34\~170 points, the higher the score, the worse the quality of life

    pretest

  • Irritable Bowel Syndrome Quality of Life

    This questionnaire has a total of 34 questions, all of which are positive questions, and are scored with five points, divided into 1 point = completely no, 2 points = a little bit, 3 points = medium, 4 points = equivalent, 5 points = extreme. The score range is 34\~170 points, the higher the score, the worse the quality of life

    2 weeks after the pretest

  • Irritable Bowel Syndrome Quality of Life

    This questionnaire has a total of 34 questions, all of which are positive questions, and are scored with five points, divided into 1 point = completely no, 2 points = a little bit, 3 points = medium, 4 points = equivalent, 5 points = extreme. The score range is 34\~170 points, the higher the score, the worse the quality of life

    4 weeks after the pretest

  • Irritable Bowel Syndrome Quality of Life

    This questionnaire has a total of 34 questions, all of which are positive questions, and are scored with five points, divided into 1 point = completely no, 2 points = a little bit, 3 points = medium, 4 points = equivalent, 5 points = extreme. The score range is 34\~170 points, the higher the score, the worse the quality of life

    8 weeks after the pretest

  • Bristol Stool Form Scale

    The first and second types of stool show that the patient has constipation, the first type is more serious than the second type; the normal stool types are the third and fourth types, and the fifth to seventh types are suspected Diarrhea (Lewis, \& Heaton, 1997), the above description indicates that the lower the score, the more severe the constipation symptoms, and vice versa, the more severe the diarrhea symptoms

    pretest

  • Bristol Stool Form Scale

    The first and second types of stool show that the patient has constipation, the first type is more serious than the second type; the normal stool types are the third and fourth types, and the fifth to seventh types are suspected Diarrhea (Lewis, \& Heaton, 1997), the above description indicates that the lower the score, the more severe the constipation symptoms, and vice versa, the more severe the diarrhea symptoms

    2 weeks after the pretest

  • Bristol Stool Form Scale

    The first and second types of stool show that the patient has constipation, the first type is more serious than the second type; the normal stool types are the third and fourth types, and the fifth to seventh types are suspected Diarrhea (Lewis, \& Heaton, 1997), the above description indicates that the lower the score, the more severe the constipation symptoms, and vice versa, the more severe the diarrhea symptoms

    4 weeks after the pretest

  • Bristol Stool Form Scale

    The first and second types of stool show that the patient has constipation, the first type is more serious than the second type; the normal stool types are the third and fourth types, and the fifth to seventh types are suspected Diarrhea (Lewis, \& Heaton, 1997), the above description indicates that the lower the score, the more severe the constipation symptoms, and vice versa, the more severe the diarrhea symptoms

    8 weeks after the pretest

Other Outcomes (17)

  • Part 1: Basic personal information:Basic and disease information list 1

    pretest

  • Part 1: Basic personal information:Basic and disease information list 2

    pretest

  • Part 1: Basic personal information:Basic and disease information list 3

    pretest

  • +14 more other outcomes

Study Arms (2)

acupuncture-like transcutaneous electrical nerve stimulation

EXPERIMENTAL

1. The experimental group received acupuncture-like transcutaneous electrical nerve stimulation three times a week for 4 weeks. 2. Invention and control groups are 4 weeks and 3 weeks respectively. Each time will be for 20 minutes acupuncture-like transcutaneous electrical nerve stimulation treatment

Device: acupuncture-like transcutaneous electrical nerve stimulation

Control group:conventional therapy

NO INTERVENTION

The control group will receive routine care.

Interventions

The intervention group performed Al-TENS therapy 3 times a week for at least 20 minutes each time for 4 consecutive weeks. The second, fourth, and eighth week after the intervention.

acupuncture-like transcutaneous electrical nerve stimulation

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Those who are at least 20 years old (inclusive) and are willing to sign a written informed consent after explaining the purpose of the research.
  • A patient with irritable bowel syndrome diagnosed by a doctor for at least 6 months (inclusive).
  • Communicate in Mandarin or Hokkien.

You may not qualify if:

  • Those who cannot take care of themselves in daily life.
  • Those who have had severe abdominal and colorectal surgery.
  • Those who have been diagnosed with inflammatory bowel disease or colorectal cancer.
  • Those with a history of mental illness, such as schizophrenia and obsessive- compulsive disorder.
  • Women who are pregnant, breastfeeding, and less than 12 months after delivery.
  • Other serious diseases, such as acute myocardial infarction, endocrine disease, decompensated cirrhosis, stroke, and end-stage renal disease, etc.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tsu Ying Fang

New Taipei City, 237, Taiwan

Location

MeSH Terms

Conditions

Irritable Bowel Syndrome

Condition Hierarchy (Ancestors)

Colonic Diseases, FunctionalColonic DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

September 4, 2021

First Posted

September 13, 2021

Study Start

February 1, 2021

Primary Completion

February 13, 2023

Study Completion

February 13, 2023

Last Updated

January 6, 2026

Record last verified: 2023-02

Locations